Devicor Mammotome Hydromark Breast Biopsy Site Marker

Singapore - English - HSA (Health Sciences Authority)

Buy It Now

Available from:
MEDQUEST MARKETING PTE LTD
Class:
Class D medical device
Manufactured by:
Devicor Medical Products, Inc.
Therapeutic area:
General & Plastic Surgery
Therapeutic indications:
To mark tissue during a percutaneous breast biopsy procedure, be visible under ultrasound for at least 6 weeks, and be permanently visible by x-ray and MRI.
Product summary:
Models: HydroMARK® Breast Biopsy Site Marker - 4010-02-15-T1, HydroMARK® Breast Biopsy Site Marker - 4010-02-15-T3, HydroMARK® Breast Biopsy Site Marker - 4010-02-15-T4, HydroMARK® Breast Biopsy Site Marker - 4010-02-18-T3, HydroMARK® Breast Biopsy Site Marker - 4010-01-11-T1, HydroMARK® Breast Biopsy Site Marker - 4010-01-11-T3, HydroMARK® Breast Biopsy Site Marker - 4010-01-11-T4, HydroMARK® Breast Biopsy Site Marker - 4010-01-08-T1, HydroMARK® Breast Biopsy Site Marker - 4010-01-08-T3, HydroMARK® Breast Biopsy Site Marker - 4010-01-08-T4, HydroMARK® Breast Biopsy Site Marker - 4010-04-09-T1, HydroMARK® Breast Biopsy Site Marker - 4010-04-09-T3, HydroMARK® Breast Biopsy Site Marker - 4010-04-09-T4, HydroMARK® Breast Biopsy Site Marker - 4010-03-15-T1, HydroMARK® Breast Biopsy Site Marker - 4010-03-15-T3, HydroMARK® Breast Biopsy Site Marker - 4010-03-15-T1-SHORT, HydroMARK® Breast Biopsy Site Marker - 4010-03-15-T3-SHORT, HydroMARK® Breast Biopsy Site Marker - 4010-03-09-T1, HydroMARK® Breast Biopsy Site Marker - 4010-03-09-T3
Authorization number:
DE0018288
Authorization date:
2016-06-24

Search alerts related to this product

Share this information